Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation

Hematol Oncol Stem Cell Ther. 2013 Jun;6(2):71. doi: 10.1016/j.hemonc.2013.05.002. Epub 2013 May 23.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Cord Blood Stem Cell Transplantation*
  • Cyclophosphamide / therapeutic use
  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Female
  • Graft vs Host Disease / prevention & control
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Magnetic Resonance Imaging
  • Posterior Leukoencephalopathy Syndrome / diagnostic imaging
  • Posterior Leukoencephalopathy Syndrome / etiology*
  • Radiography
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use
  • Whole-Body Irradiation

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Cyclophosphamide
  • Vidarabine
  • fludarabine